Core LaboratoriesCLB.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, Core Laboratories (CLB.N) trades at a P/E of 17.30x, P/B of 1.69x, P/S of 0.88x, and a dividend yield of 0.30%.
Longitudinal percentile comparison: P/E sits at the 4th percentile over the trailing 10Y window (vs. 6th percentile over 3Y); P/B sits at the 0th percentile over the trailing 10Y window (vs. 1st percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 1st percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 60th percentile within its industry and the 45th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.01%, ranking at the 61st percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 4.1 points of each other — a consistent signal from both angles. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Of the 3.01% total shareholder yield, 0.30% is paid out as dividends and roughly 2.71% is implied to come from buybacks — both channels are meaningfully in play. Core Laboratories operates in the Mining sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: CLB · CLB
Want the full picture on whether Core Laboratories (CLB.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 17.30 | ||||||
| P/B (MRQ) | 1.69 | ||||||
| P/S (TTM) | 0.88 | ||||||
| Dividend Yield | 0.30% | ||||||
| Buyback + Div Yield | 3.01% |